-
Will Right to Try Increase Access to Experimental Treatments?
The recently passed Right to Try Act is meant to provide patients with greater access to experimental therapies. Patient advocates are divided on whether the law will benefit patients.
by Marci A. Landsmann
-
What Older Patients Value
Many older adults with cancer place more importance on maintaining their independence and cognitive abilities than on living as long as possible.
by Cheryl Platzman Weinstock
-
Omitting Obesity
Many cancer clinical trials do not track what proportion of enrolled patients are obese, a study finds. These patients may be underrepresented in research.
by Cici Zhang
-
Questioning an Entrenched Practice
To defend against bacterial infections, cancer patients are often put on a neutropenic diet—which bars fresh fruits and vegetables, among other things. Research indicates that following this diet is unnecessary.
by Brad Jones
-
Cancer Patients Who Are Parents
Patients who are diagnosed with advanced cancer while parenting young children have special priorities and needs.
by Cheryl Platzman Weinstock
-
Advocacy Spotlight: Sorting Out Priorities
Ovarian cancer survivor and research advocate Annie Ellis is teaming up with researchers to better equip patients with recurrent cancer to make treatment decisions.
by Cici Zhang
-
Bill Aims to Improve Childhood Cancer Research
The STAR Act passes in the U.S. House of Representatives.
by Brad Jones
-
Measuring Your Movement
Researchers are exploring whether wearable personal activity monitors could provide doctors with a more complete picture of cancer patients' well-being.
by Brad Jones
-
Talking About Medical Marijuana
Medical oncologists discuss marijuana with their patients. Many of these doctors feel they aren't well enough informed to make recommendations about it, but some do anyway.
by Kate Yandell
-
Men Less Likely to Get Genetic Testing
A study suggests women are more likely than men to undergo genetic testing for mutations linked to hereditary cancer.
by Cheryl Platzman Weinstock
Cancer Talk
Declining Breast Cancer Mortality in Younger Women
U.S. breast cancer deaths declined for women ages 20 to 49, which researchers credit to wider screening and better treatment.
by Kevin McLaughlin
Missed Activities Due to Cancer-related Fatigue and DepressionWomen were more likely than men to have fatigue or depression linked to cancer, and both effects were linked to people withdrawing from physical activities.
by Eric Fitzsimmons
Immunotherapy Improves Results in Head and Neck CancerCombining an immune checkpoint inhibitor with standard care extended event-free survival by nearly two years.
by Thomas Celona
Federal Support for Cancer Research Takes the Stage at AACR Annual MeetingScientists and former administrators gather for session focused on advocating for cancer research in uncertain times.
by Kevin McLaughlin